HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H959. A total of 3 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699 | +181.9% | 18,300 | +165.2% | 0.00% | – |
| Q2 2023 | $248 | +45.0% | 6,900 | +53.3% | 0.00% | – |
| Q1 2023 | $171 | -95.3% | 4,500 | -92.9% | 0.00% | -100.0% |
| Q4 2022 | $3,618 | -99.4% | 63,600 | +292.6% | 0.00% | +300.0% |
| Q3 2022 | $640,000 | +329.5% | 16,200 | +376.5% | 0.00% | – |
| Q2 2022 | $149,000 | +684.2% | 3,400 | +580.0% | 0.00% | – |
| Q1 2022 | $19,000 | -94.4% | 500 | -94.1% | 0.00% | – |
| Q4 2021 | $341,000 | -72.9% | 8,500 | -68.6% | 0.00% | -100.0% |
| Q3 2021 | $1,256,000 | +2.1% | 27,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,230,000 | – | 27,100 | +9375.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 286 | +302.8% | 0.00% | – |
| Q4 2020 | $303,000 | -31.8% | 71 | -58.0% | 0.00% | -100.0% |
| Q3 2020 | $444,000 | -37.0% | 169 | -35.7% | 0.00% | 0.0% |
| Q2 2020 | $705,000 | +153.6% | 263 | +69.7% | 0.00% | – |
| Q1 2020 | $278,000 | +36.9% | 155 | +34.8% | 0.00% | – |
| Q4 2019 | $203,000 | +157.0% | 115 | +125.5% | 0.00% | – |
| Q3 2019 | $79,000 | -3.7% | 51 | +6.2% | 0.00% | – |
| Q2 2019 | $82,000 | -46.1% | 48 | -49.5% | 0.00% | – |
| Q1 2019 | $152,000 | +90.0% | 95 | +72.7% | 0.00% | – |
| Q4 2018 | $80,000 | +220.0% | 55 | +292.9% | 0.00% | – |
| Q3 2018 | $25,000 | -69.5% | 14 | -71.4% | 0.00% | – |
| Q2 2018 | $82,000 | +4000.0% | 49 | +172.2% | 0.00% | – |
| Q1 2018 | $2,000 | -50.0% | 18 | -80.2% | 0.00% | – |
| Q4 2017 | $4,000 | -55.6% | 91 | -37.2% | 0.00% | – |
| Q3 2017 | $9,000 | -82.0% | 145 | -59.0% | 0.00% | -100.0% |
| Q2 2017 | $50,000 | -7.4% | 354 | +46.3% | 0.00% | 0.0% |
| Q1 2017 | $54,000 | -49.5% | 242 | -29.4% | 0.00% | -66.7% |
| Q4 2016 | $107,000 | +234.4% | 343 | +156.0% | 0.01% | +200.0% |
| Q3 2016 | $32,000 | -31.9% | 134 | +13.6% | 0.00% | -33.3% |
| Q2 2016 | $47,000 | +370.0% | 118 | -16.9% | 0.00% | +200.0% |
| Q1 2016 | $10,000 | -63.0% | 142 | -37.4% | 0.00% | -50.0% |
| Q4 2015 | $27,000 | +22.7% | 227 | +23.4% | 0.00% | 0.0% |
| Q3 2015 | $22,000 | +214.3% | 184 | -34.8% | 0.00% | +100.0% |
| Q2 2015 | $7,000 | -72.0% | 282 | +50.8% | 0.00% | -66.7% |
| Q1 2015 | $25,000 | +13.6% | 187 | +12.0% | 0.00% | 0.0% |
| Q4 2014 | $22,000 | – | 167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 532 | $526,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 95,400 | $943,000 | 0.01% |
| SIMPLEX TRADING, LLC | 343 | $107,000 | 0.01% |